Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dilip Thomas

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cell Reports|July 16, 2020
Modeling Secondary Iron Overload Cardiomyopathy with Human Induced Pluripotent Stem Cell-Derived CardiomyocytesJune-Wha Rhee, Hyoju Yi, Dilip Thomas, et al.
Circulation|April 25, 2022
Modeling Effects of Immunosuppressive Drugs on Human Hearts Using Induced Pluripotent Stem Cell-Derived Cardiac Organoids and Single-Cell RNA SequencingKarim Sallam, Dilip Thomas, Sadhana Gaddam, et al.
Science Translational Medicine|December 17, 2025
Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotectiveAmit Manhas, Yu Liu, Chikage Noishiki, et al.
Biomaterials|January 25, 2021
Elastin-like hydrogel stimulates angiogenesis in a severe model of critical limb ischemia (CLI): An insight into the glyco-host responseGrazia Marsico, Chunseng Jin, Sunny A Abbah, et al.
Nature Biomedical Engineering|April 25, 2019
Stimulation of 3D osteogenesis by mesenchymal stem cells using a nanovibrational bioreactorPenelope M Tsimbouri, Peter G Childs, Gabriel D Pemberton, et al.
Nature Biomedical Engineering|April 25, 2019
Publisher Correction: Stimulation of 3D osteogenesis by mesenchymal stem cells using a nanovibrational bioreactorPenelope M Tsimbouri, Peter G Childs, Gabriel D Pemberton, et al.
Cell Stem Cell|November 8, 2024
CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicityChun Liu, Mengcheng Shen, Yanxia Liu, et al.
Nature Cardiovascular Research|October 14, 2024
CCL2-mediated endothelial injury drives cardiac dysfunction in long COVIDDilip Thomas, Chikage Noishiki, Sadhana Gaddam, et al.
Nature|April 30, 2025
Selective inhibition of stromal mechanosensing suppresses cardiac fibrosisSangkyun Cho, Siyeon Rhee, Christopher M Madl, et al.
Cell Stem Cell|February 2, 2021
Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genesParisha P Shah, Wenjian Lv, Joshua H Rhoades, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cell Reports|July 16, 2020
Modeling Secondary Iron Overload Cardiomyopathy with Human Induced Pluripotent Stem Cell-Derived CardiomyocytesJune-Wha Rhee, Hyoju Yi, Dilip Thomas, et al.
Circulation|April 25, 2022
Modeling Effects of Immunosuppressive Drugs on Human Hearts Using Induced Pluripotent Stem Cell-Derived Cardiac Organoids and Single-Cell RNA SequencingKarim Sallam, Dilip Thomas, Sadhana Gaddam, et al.
Science Translational Medicine|December 17, 2025
Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotectiveAmit Manhas, Yu Liu, Chikage Noishiki, et al.
Biomaterials|January 25, 2021
Elastin-like hydrogel stimulates angiogenesis in a severe model of critical limb ischemia (CLI): An insight into the glyco-host responseGrazia Marsico, Chunseng Jin, Sunny A Abbah, et al.
Nature Biomedical Engineering|April 25, 2019
Stimulation of 3D osteogenesis by mesenchymal stem cells using a nanovibrational bioreactorPenelope M Tsimbouri, Peter G Childs, Gabriel D Pemberton, et al.
Nature Biomedical Engineering|April 25, 2019
Publisher Correction: Stimulation of 3D osteogenesis by mesenchymal stem cells using a nanovibrational bioreactorPenelope M Tsimbouri, Peter G Childs, Gabriel D Pemberton, et al.
Cell Stem Cell|November 8, 2024
CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicityChun Liu, Mengcheng Shen, Yanxia Liu, et al.
Nature Cardiovascular Research|October 14, 2024
CCL2-mediated endothelial injury drives cardiac dysfunction in long COVIDDilip Thomas, Chikage Noishiki, Sadhana Gaddam, et al.
Nature|April 30, 2025
Selective inhibition of stromal mechanosensing suppresses cardiac fibrosisSangkyun Cho, Siyeon Rhee, Christopher M Madl, et al.
Cell Stem Cell|February 2, 2021
Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genesParisha P Shah, Wenjian Lv, Joshua H Rhoades, et al.
Pageof 5